World's Best Scientists 2026 revealed!
Award Badge
Medicine
Italy
2023

D-Index & Metrics

Neuroscience

D-Index
162
Citations
122468
World Ranking
101
National Ranking
1

Research.com Recognitions

  • 2023 - Research.com Medicine in Italy Leader Award

Overview

Giancarlo Comi was affiliated with Vita-Salute San Raffaele University in Italy. Their research primarily focused on the field of Medicine, with significant contributions to subfields such as Pathology and Forensic Medicine, Immunology, Oncology, Rheumatology, and Public Health, Environmental and Occupational Health.

The work of Giancarlo Comi covered multiple topics, with an emphasis on:

  • Multiple Sclerosis Research Studies
  • Polyomavirus and related diseases
  • Rheumatoid Arthritis Research and Therapies
  • Peripheral Neuropathies and Disorders
  • Reproductive System and Pregnancy
  • Acute Lymphoblastic Leukemia research
  • SARS-CoV-2 and COVID-19 Research

Their publication record included several recent papers such as:

  • Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis, 2020, Brain
  • Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis, 2021, Neurology
  • Vaccinations in patients with multiple sclerosis: A Delphi consensus statement, 2020, Multiple Sclerosis Journal
  • Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis, 2021, JAMA Neurology
  • Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study, 2020, CNS Drugs

The frequent co-authors working alongside Giancarlo Comi included:

  • Francesco Patti
  • Maria Pia Amato
  • Massimo Filippi
  • Eleonora Cocco
  • María Trojano

Most of their research was published in the following venues:

  • Neurology
  • Multiple Sclerosis Journal
  • Journal of Neurology
  • Brain
  • JAMA Neurology

In addition to journal articles, Giancarlo Comi contributed to book publications. One known book was published by Frontiers Media titled Use of Big Data and Artificial Intelligence in Multiple Sclerosis, expected in 2025.

Best Publications

  • Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

    Alan J. Thompson;Brenda L. Banwell;Frederik Barkhof;Frederik Barkhof;William M. Carroll

  • Defining the clinical course of multiple sclerosis: The 2013 revisions

    Fred D. Lublin;Stephen C. Reingold;Jeffrey A. Cohen;Gary R. Cutter

  • Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

    Frederik Barkhof;Massimo Filippi;David H. Miller;Philip Scheltens

  • Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study.

    Giancarlo Comi;Massimo Filippi;Frederik Barkhof;Luca Durelli

  • Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis

    Stefano Pluchino;Angelo Quattrini;Elena Brambilla;Angela Gritti

  • European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis

    Giancarlo Comi;Massimo Filippi;Jerry S. Wolinsky

  • ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

    X. Montalban;R. Gold;A. J. Thompson;S. Otero‐Romero

  • Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism.

    Stefano Pluchino;Lucia Zanotti;Barbara Rossi;Elena Brambilla

  • White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging

    M Bozzali;A Falini;M Franceschi;M Cercignani

  • Autoantibodies to Glutamic Acid Decarboxylase in a Patient with Stiff-Man Syndrome, Epilepsy, and Type I Diabetes Mellitus

    M. Solimena;F. Folli;S. Denis-Donini;G. C. Comi

  • IFCN standards for digital recording of clinical EEG

    Marc R. Nuwer;Giancarlo Comi;Ronald Emerson;Anders Fuglsang-Frederiksen

  • Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.

    Christian Confavreux;Paul O'Connor;Giancarlo Comi;Mark S. Freedman

  • Diffusion tensor magnetic resonance imaging in multiple sclerosis

    Massimo Filippi;M. Cercignani;M. Inglese;M. A. Horsfield

  • Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy

    R Hughes;Peter Van den Bergh;S Bensa;H Willison

  • Early Hemorrhagic Transformation of Brain Infarction: Rate, Predictive Factors, and Influence on Clinical Outcome Results of a Prospective Multicenter Study

    Maurizio Paciaroni;Giancarlo Agnelli;Francesco Corea;Walter Ageno

  • Multiple sclerosis progression: time for a new mechanism-driven framework

    Unknown

  • Association between pathological and MRI findings in multiple sclerosis

    Massimo Filippi;Maria A. Rocca;Frederik Barkhof;Wolfgang Brück

  • A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis

    M. Filippi;A. Campi;V. Dousset;C. Baratti

  • Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo- controlled, randomized phase II trial

    Ludwig Kappos;Giancarlo Comi;Hillel Panitch;Joel Oger

  • 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

    Paul O'Connor;Massimo Filippi;Barry Arnason;Giancarlo Comi

  • Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis

    Massimo Filippi;Maria A. Rocca;Gianvito Martino;Mark A. Horsfield

  • Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.

    Massimo Filippi;M. Bozzali;M. Rovaris;O. Gonen

Frequent Co-Authors

Maria A. Rocca
Maria A. Rocca Vita-Salute San Raffaele University
Vittorio Martinelli
Vittorio Martinelli Vita-Salute San Raffaele University
Federica Agosta
Federica Agosta Vita-Salute San Raffaele University
Letizia Leocani
Letizia Leocani University of Milan
Bruno Colombo
Bruno Colombo Vita-Salute San Raffaele University
Elisabetta Pagani
Elisabetta Pagani Vita-Salute San Raffaele University
Giuseppe Magnani
Giuseppe Magnani Vita-Salute San Raffaele University
Paola Valsasina
Paola Valsasina Vita-Salute San Raffaele University
Elisa Canu
Elisa Canu Vita-Salute San Raffaele University
Douglas L. Arnold
Douglas L. Arnold Montreal Neurological Institute and Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a neuroscience career starts with the right education. Many students now choose flexible online programs to balance their studies with other commitments. For those eager to fast-track their education, 2 year accelerated bachelor degrees online offer a quicker route to graduation, making it easier to jumpstart a neuroscience career.

Neuroscience is an interdisciplinary field closely linked to biology, psychology, and even computer science. While passion is important, it's wise to consider the financial side as well. Reviewing degrees that pay well and exploring the most lucrative majors can help you align your studies with rewarding job prospects and long-term earning potential.

Investing in an online degree doesn't have to mean sacrificing affordability. There are online colleges that offer financial aid, making it possible for more students to access high-quality neuroscience programs without overwhelming debt. Balancing speed, future salary, and affordability can help you build a successful pathway in neuroscience.

Best Scientists Citing Giancarlo Comi